Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(4 sites)

Poland

Regional Cancer Centre in Opole, Opole, Opole Voivodeship

Maria Sklodowska-Curie Institute - Oncology Centre (MSCI), Gliwice Branch, Gliwice, Silesian Voivodeship

Silesian Center for Heart Diseases, Zabrze, Silesian Voivodeship

Holy Cross Cancer Centre, Cardio-Oncology Division, Kielce, Świętokrzyskie Voivodeship